KBLB — Kraig Biocraft Laboratories Cashflow Statement
0.000.00%
Last trade - 00:00- $96.20m
- $101.43m
- 31
- 47
- 34
- 29
Annual cashflow statement for Kraig Biocraft Laboratories, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -4.97 | -8.05 | -3.84 | -3.03 | -3.4 |
| Depreciation | |||||
| Non-Cash Items | 2.95 | 5.6 | 1.43 | 0.884 | 0.803 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.734 | 0.618 | 0.5 | 0.873 | 0.731 |
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -1.25 | -1.8 | -1.89 | -1.24 | -1.84 |
| Capital Expenditures | — | -0.097 | -0.005 | -0.006 | -0.004 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | -0.45 | 0 | 0 | 0 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | — | -0.547 | -0.005 | -0.006 | -0.004 |
| Financing Cash Flow Items | -0.069 | 0 | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.95 | 3.89 | 3.4 | -0.06 | -0.035 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.692 | 1.54 | 1.51 | -1.31 | -1.88 |